Opko Health (OPK) Posts Q1 Loss of 11c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts OPK Hot Sheet
Price: $1.76 +2.33%
EPS Growth %: -333.3%
Financial Fact:
Product sales: 20.57M
Today's EPS Names:
ATS, SICP, FTCO, More
EPS Growth %: -333.3%
Financial Fact:
Product sales: 20.57M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Opko Health (NYSE: OPK) reported Q1 EPS of ($0.11), $0.01 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $22.3 million versus the consensus estimate of $22.77 million.
For earnings history and earnings-related data on Opko Health (OPK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo starts On Holding at Overweight, sees growth reaccelerating in 2027
- Contineum Therapeutics (CTNM) PT Lowered to $23 at Stifel
- Red Rock Resorts (RRR) PT Lowered to $60 at StoneX
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
